AUSTRALIAN CANNABIS COMPANY BREAKS INTO LUCRATIVE CANADIAN MARKET

AUSTRALIAN CANNABIS COMPANY BREAKS INTO LUCRATIVE CANADIAN MARKET
MEDICINAL cannabis company Creso Pharma (ASX: CPH) has broken into the North American market with the acquisition of Canadian cannabis production company Mernova Medicinal in exchange for $10.2 million worth of cash and equity.

Creso's deal means it will be the only Australian cannabis company with direct access to the world's largest medicinal cannabis market and will allow it to produce its own products in Canada.

The company, which develops treatments for both humans and animals, has offices in Perth, Sydney and Switzerland all working to develop non-psychoactive cannabinoid-based products to assist with health and relieve conditions including pain, anxiety, metabolic disorders and inflammatory disorders.

CEO and Co-Founder of Creso Pharma Dr Miri Halperin Wernli says the acquisition will provide the company with opportunities for expansion, manufacturing, innovation and exportation.

"This move gives Creso a number of strategic benefits, not only when it comes to expanding to overseas markets, but also when it comes to cultivating and manufacturing our own innovative medicinal cannabis products," says Wernli.

"We're also looking forward to pursuing further opportunities in the Canadian market, when it comes to both local distribution and exporting to other countries such as Australia that already accept medicinal cannabis imports."

Canadian legislation requires companies to prove they can cultivate cannabis crop before they can be issued a cultivation license which Mernova Medicinal has applied for and is expected to receive as the first in the Canadian Nova Scotia district.

If all goes to plan the first cannabis crop is expected to be produced in a year and the revenue potential for the first crop alone is predicted to be worth between $15.9 million and $31.8 million per annum.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Advertisement

Related Stories

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Federal Court finds Google misled consumers on data collection

Federal Court finds Google misled consumers on data collection

The Federal Court has found Google misled consumers about persona...

Redflow charging up ahead of next-gen battery launch

Redflow charging up ahead of next-gen battery launch

Redflow (ASX: RFX) is gearing up to launch the next generation of...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...